Mathematical modeling provides kinetic details of the human immune response to vaccination

With major advances in experimental techniques to track antigen-specific immune responses many basic questions on the kinetics of virus-specific immunity in humans remain unanswered. To gain insights into kinetics of T and B cell responses in human volunteers we combined mathematical models and experimental data from recent studies employing vaccines against yellow fever and smallpox. Yellow fever virus-specific CD8 T cell population expanded slowly with the average doubling time of 2 days peaking 2.5 weeks post immunization. Interestingly, we found that the peak of the yellow fever-specific CD8 T cell response was determined by the rate of T cell proliferation and not by the precursor frequency of antigen-specific cells as has been suggested in several studies in mice. We also found that while the frequency of virus-specific T cells increased slowly, the slow increase could still accurately explain clearance of yellow fever virus in the blood. Our additional mathematical model described well the kinetics of virus-specific antibody-secreting cell and antibody response to vaccinia virus in vaccinated individuals suggesting that most of antibodies in 3 months post immunization were derived from the population of circulating antibody-secreting cells. Taken together, our analysis provided novel insights into mechanisms by which live vaccines induce immunity to viral infections and highlighted challenges of applying methods of mathematical modeling to the current, state-of-the-art yet limited immunological data.

[1]  A. Rothman,et al.  Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E. , 2002, Virology.

[2]  Alan S. Perelson,et al.  Different Dynamics of CD4+ and CD8+ T Cell Responses During and After Acute Lymphocytic Choriomeningitis Virus Infection 1 , 2003, The Journal of Immunology.

[3]  Sebastian Bonhoeffer,et al.  Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis , 1999, The Lancet.

[4]  M. Albert,et al.  Enumeration of human antigen-specific naive CD8+ T cells reveals conserved precursor frequencies. , 2010, Blood.

[5]  B. Rehermann,et al.  Immune responses to HCV and other hepatitis viruses. , 2014, Immunity.

[6]  W Chen,et al.  Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. , 2000, Immunity.

[7]  Mark M. Davis,et al.  Antiviral memory phenotype T cells in unexposed adults , 2013, Immunological reviews.

[8]  Rob J de Boer,et al.  A general functional response of cytotoxic T lymphocyte-mediated killing of target cells. , 2014, Biophysical journal.

[9]  Alan S. Perelson,et al.  Recruitment Times, Proliferation, and Apoptosis Rates during the CD8+ T-Cell Response to Lymphocytic Choriomeningitis Virus , 2001, Journal of Virology.

[10]  L. Lefrançois,et al.  Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection. , 2008, Immunity.

[11]  F. Guirakhoo,et al.  Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax™-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All , 2006, Human vaccines.

[12]  G. Nossal,et al.  Elaboration of antibodies by single cells. , 1962, Annual review of microbiology.

[13]  A. Perelson Modelling viral and immune system dynamics , 2002, Nature Reviews Immunology.

[14]  M. Slifka,et al.  How advances in immunology provide insight into improving vaccine efficacy. , 2014, Vaccine.

[15]  Klaus Rajewsky,et al.  The half‐lives of serum immunoglobulins in adult mice , 1988, European journal of immunology.

[16]  P. Doherty,et al.  Primary CTL response magnitude in mice is determined by the extent of naive T cell recruitment and subsequent clonal expansion. , 2010, The Journal of clinical investigation.

[17]  J. Hoxie,et al.  Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor , 2014, Science Translational Medicine.

[18]  David Kotlyar CD8 T Cells , 2016 .

[19]  Christian Stemberger,et al.  A single naive CD8+ T cell precursor can develop into diverse effector and memory subsets. , 2007, Immunity.

[20]  R. Ahmed,et al.  Cytotoxic T-cell memory without antigen , 1994, Nature.

[21]  N. Ferguson,et al.  Time lines of infection and disease in human influenza: a review of volunteer challenge studies. , 2008, American journal of epidemiology.

[22]  M. Mbow,et al.  Infiltration of CD4+ CD8+ T cells, and expression of ICAM-1, Ia antigens, IL-1 alpha and TNF-alpha in the skin lesion of BALB/c mice undergoing repeated infestations with nymphal Ixodes ricinus ticks. , 1994, Immunology.

[23]  F. Trepel,et al.  Number and distribution of lymphocytes in man. A critical analysis , 1974, Klinische Wochenschrift.

[24]  M. Niedrig,et al.  Safety profile of the yellow fever vaccine Stamaril®: a 17-year review , 2013, Expert review of vaccines.

[25]  H. Dosch,et al.  Limiting dilution analysis of the B cell compartment in human bone marrow , 1986, European journal of immunology.

[26]  A S Perelson,et al.  Target cell limited and immune control models of HIV infection: a comparison. , 1998, Journal of theoretical biology.

[27]  C. Rice,et al.  The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD 8 T Cell Response 1 , 2009 .

[28]  B. Haynes,et al.  Distinct Kinetics of Gag-Specific CD4+ and CD8+ T Cell Responses during Acute HIV-1 Infection , 2012, Journal of Immunology.

[29]  R J D B,et al.  Target Cell Limited and Immune Control Models of HIV Infection : A Comparison , 1998 .

[30]  Uri Hershberg,et al.  Taking Advantage: High-Affinity B Cells in the Germinal Center Have Lower Death Rates, but Similar Rates of Division, Compared to Low-Affinity Cells1 , 2009, The Journal of Immunology.

[31]  Rate of hemolytic antibody production by single cells in vivo in rabbits. , 1974, Journal of immunology.

[32]  J. Altman,et al.  Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. , 2008, Immunity.

[33]  G. Gerna Endothelial cells and CMV dissemination. , 2012, Future microbiology.

[34]  Nichole E Carlson,et al.  Duration of humoral immunity to common viral and vaccine antigens. , 2007, The New England journal of medicine.

[35]  Susan M. Kaech,et al.  Transcriptional control of effector and memory CD8+ T cell differentiation , 2012, Nature Reviews Immunology.

[36]  R. Ahmed,et al.  Humoral immunity due to long-lived plasma cells. , 1998, Immunity.

[37]  J. Altman,et al.  Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. , 1998, Immunity.

[38]  Persephone Borrow,et al.  The immune response during acute HIV-1 infection: clues for vaccine development , 2009, Nature Reviews Immunology.

[39]  Philip J. R. Goulder,et al.  Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.

[40]  Claudia Henry,et al.  Plaque Forming Cells: Methodology and Theory , 1974, Transplantation reviews.

[41]  Vitaly V. Ganusov,et al.  Estimating In Vivo Death Rates of Targets due to CD8 T-Cell-Mediated Killing , 2008, Journal of Virology.

[42]  M. Slifka Vaccine-Mediated Immunity Against Dengue and the Potential for Long-Term Protection Against Disease , 2014, Front. Immunol..

[43]  Douglas M. Bates,et al.  Nonlinear Regression Analysis and Its Applications , 1988 .

[44]  Rustom Antia,et al.  The role of models in understanding CD8+ T-cell memory , 2005, Nature Reviews Immunology.

[45]  Matthew S. Lewis,et al.  Immune clearance of highly pathogenic SIV infection , 2013, Nature.

[46]  E. Gotuzzo,et al.  Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years. , 2013, The American journal of tropical medicine and hygiene.

[47]  K. Rajewsky,et al.  The bulk of endogenously produced IgG2a is eliminated from the serum of adult C57BL/6 mice with a half‐life of 6–8 days , 1986, European journal of immunology.

[48]  P. Doherty,et al.  Accessing complexity: the dynamics of virus-specific T cell responses. , 2000, Annual review of immunology.

[49]  M. Alyanakian,et al.  Pharmacokinetics of total immunoglobulin G and immunoglobulin G subclasses in patients undergoing replacement therapy for primary immunodeficiency syndromes , 2003, Vox sanguinis.

[50]  Jeremy Auerbach,et al.  Mathematical Modeling Reveals Kinetics of Lymphocyte Recirculation in the Whole Organism , 2014, PLoS Comput. Biol..

[51]  R. Ahmed,et al.  Insights into human CD8+ T‐cell memory using the yellow fever and smallpox vaccines , 2011, Immunology and cell biology.

[52]  R Stalnikowicz-Darvasi,et al.  Gastrointestinal bleeding during low-dose aspirin administration for prevention of arterial occlusive events. A critical analysis. , 1995, Journal of clinical gastroenterology.

[53]  Bjoern Peters,et al.  Naive Precursor Frequencies and MHC Binding Rather Than the Degree of Epitope Diversity Shape CD8+ T Cell Immunodominance1 , 2008, The Journal of Immunology.

[54]  G. Pantaleo,et al.  Immune response to HIV , 2013, Current opinion in HIV and AIDS.

[55]  Lloyd Demetrius,et al.  Of mice and men , 2005, EMBO reports.

[56]  K. Murali‐Krishna,et al.  CD8 T Cell Expansion and Memory Differentiation Are Facilitated by Simultaneous and Sustained Exposure to Antigenic and Inflammatory Milieu1 , 2008, The Journal of Immunology.

[57]  Measurement of antibody release from single cells. II. , 1972, Journal of immunology.

[58]  Alan S. Perelson,et al.  Kinetics of Virus-Specific CD8+ T Cells and the Control of Human Immunodeficiency Virus Infection , 2004, Journal of Virology.

[59]  Patrick C. Wilson,et al.  Rapid cloning of high-affinity human monoclonal antibodies against influenza virus , 2008, Nature.

[60]  C. Althaus,et al.  Dynamics of CD8+ T Cell Responses during Acute and Chronic Lymphocytic Choriomeningitis Virus Infection1 , 2007, The Journal of Immunology.

[61]  I. Turesson Distribution of immunoglobulin-containing cells in human bone marrow and lymphoid tissues. , 2009, Acta medica Scandinavica.

[62]  Susan M. Kaech,et al.  Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells , 2001, Nature Immunology.

[63]  A. Govaerts [Humoral immunity]. , 1978, Bruxelles medical.

[64]  I. Messaoudi,et al.  Protective immunity following vaccination: How is it defined? , 2008, Human vaccines.

[65]  E. Bromage,et al.  The third dimension of ELISPOTs: quantifying antibody secretion from individual plasma cells. , 2009, Journal of immunological methods.

[66]  Rustom Antia,et al.  Estimating the Precursor Frequency of Naive Antigen-specific CD8 T Cells , 2002, The Journal of experimental medicine.

[67]  Marion Pepper,et al.  Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. , 2007, Immunity.

[68]  A. Khoruts,et al.  Visualizing the generation of memory CD4 T cells in the whole body , 2001, Nature.

[69]  Á. L. Bertho,et al.  Detection of Th1/Th2 cytokine signatures in yellow fever 17DD first-time vaccinees through ELISpot assay. , 2008, Cytokine.

[70]  David R. Anderson,et al.  Model selection and multimodel inference : a practical information-theoretic approach , 2003 .

[71]  A. SMIm Immunoglobulin Synthesis and Total Body Tumor Cell Number in IgG Multiple Myeloma , 2022 .

[72]  Roland R. Regoes,et al.  Investigating CTL Mediated Killing with a 3D Cellular Automaton , 2009, PLoS Comput. Biol..

[73]  M H Lessof,et al.  Advances in immunology. , 1978, The Practitioner.

[74]  N. K. Jerne,et al.  Plaque Formation in Agar by Single Antibody-Producing Cells , 1963, Science.

[75]  Libin Rong,et al.  Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life , 2013, Proceedings of the National Academy of Sciences.

[76]  Michael J. Bevan,et al.  CD8+ T Cells: Foot Soldiers of the Immune System , 2011, Immunity.

[77]  S. Hansen,et al.  Duration of antiviral immunity after smallpox vaccination , 2003, Nature Medicine.

[78]  Vitaly V. Ganusov,et al.  Killing of Targets by CD8+ T Cells in the Mouse Spleen Follows the Law of Mass Action , 2011, PLoS ONE.

[79]  Lihan K. Yan,et al.  Improved Assay To Detect Neutralizing Antibody following Vaccination with Diluted or Undiluted Vaccinia (Dryvax) Vaccine , 2003, Journal of Clinical Microbiology.

[80]  M. Jenkins,et al.  The Role of Naive T Cell Precursor Frequency and Recruitment in Dictating Immune Response Magnitude , 2012, The Journal of Immunology.

[81]  Dirk Homann,et al.  Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory , 2001, Nature Medicine.

[82]  J. Salfeld,et al.  Isotype selection in antibody engineering , 2007, Nature Biotechnology.